JNTU B.Pharmacy IV NOVEL DRUG DELIVERY SYSTEMS Previous Question Paper (July/August-2022 - R17)

The physicochemical properties of a drug are critical in Controlled Drug Delivery Systems (CDDS) as they dictate the drug's stability, solubility, and absorption behavior, which in turn determine the selection of the delivery platform and the release kinetics.

1. Aqueous Solubility: Drugs with low solubility require formulation strategies like solid dispersions or micronization to ensure consistent release, whereas highly soluble drugs may require matrix systems to prevent dose dumping.
2. Partition Coefficient (Log P): This determines the drug's lipophilicity and its ability to permeate biological membranes. A balanced Log P is essential for achieving optimal bioavailability from a controlled release dosage form.
3. pKa and Ionization: The degree of ionization at physiological pH influences drug transport across membranes and its interaction with ion-exchange resins or pH-dependent polymers.
4. Stability: The drug must be chemically stable within the delivery system during the extended residence time in the gastrointestinal tract.
5. Molecular Weight: Smaller molecules generally exhibit better permeability, while larger molecules may require specific transport mechanisms or localized delivery strategies.

The ion exchange principle for controlled release relies on the reversible exchange of drug ions with oppositely charged ions present in the gastrointestinal fluids, using insoluble, cross-linked polymer resins.

The process involves two main stages:

1. Drug-Resin Complexation: The drug is loaded onto the resin by passing a drug solution through a column of ion-exchange resin. The drug binds to the resin via ionic bonds, forming a drug-resin complex (resinate).
2. Release Mechanism: Upon ingestion, the drug-resin complex encounters gastrointestinal fluids containing high concentrations of endogenous ions (e.g., Cl⁻, Na⁺, K⁺). These ions compete with the drug for the exchange sites on the resin.

The rate of drug release is governed by the concentration of ions in the GI tract and the affinity of the drug for the resin. Because the concentration of ions in the GI tract remains relatively constant, the drug is released at a controlled, predictable rate through an ion-exchange process, effectively masking the taste of bitter drugs and providing sustained therapeutic levels.